Article
Genetic risk factors and the anti-atherosclerotic effect of pioglitazone on carotid atherosclerosis of subjects with type 2 diabetes--a retrospective study.
Journal of atherosclerosis and thrombosis - 30 Apr 2010
Saitou Miyoko, Osonoi Takeshi, Kawamori Ryuzo, Katakami Naoto, Kaneto Hideaki, Matsuhisa Munehide, Yamasaki Yoshimistu
Abstract excerpt
AIM: Pioglitazone, an agonist of peroxisome proliferator-activated receptor gamma, showed various anti-atherosclerotic effects on type 2 diabetic patients. This retrospective study was done to ascertain which risk factor(s) associate with anti-atherosclerotic effects of pioglitazone. METHODS: We enrolled 160 diabetic patients treated through diet only and 62 treated with pioglitazone and annually evaluated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
